Skip to search formSkip to main contentSkip to account menu

CMFVP protocol

Known as: Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine, CVFMP protocol, VPCMF 
A combination of agents containing cyclophosphamide, fluorouracil, methotrexate, prednisone and vincristine.
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMethotrexatecisplatin/cyclophosphamide/etoposide protocol
FluorouracilPrednisoneVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Combination chemotherapy with 5-Fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer—an open Phase II study
SummaryPhase II studies of p.o. Idarubicin administration, a new daunorubicin analogue (4-demethoxydaunorubicin), have shown… 
1993
1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
PURPOSE To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide… 
1991
1991
Adjuvant combination chemotherapy cmfvp vs oophorectomy followed by cmfvp ocmfvp for premenopausal women with er positive operable breast cancer with positive axillary lymph nodes an intergroup study
1988
1988
Chemotherapy of Mammary Cancer with Anthracyclins and Alkylators
Over the past two and half decades the chemotherapy of disseminated breast cancer has involved three major stages. The first was… 
1986
1986
Adjuvant therapy of breast cancer: Southwest Oncology Group studies.
The Southwest Oncology Group has conducted a series of randomized studies of adjuvant therapy in patients with primary breast… 
1985
1985
Chemotherapy in advanced breast carcinoma. Comparison between doxorubicin-cyclophosphamide and cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone.
Two chemotherapeutic regimens were compared in 102 patients with metastatic breast carcinoma, randomized to either doxorubicin… 
1985
1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status
This is a preliminary report of the Southwest Oncology Group in which therapy is randomized by estrogen receptor (ER) data… 
1982
1982
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study.
The Cancer and Leukemia Group B (CALB) has conducted a randomized study of adjuvant chemotherapy in patients with breast cancer… 
1981
1981
Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and…
Thirty-two patients with metastatic breast cancer refractory to chemotherapy with combinations of cyclophosphamide, methotrexate… 
1981
1981
First, second and third line chemotherapy programs in metastatic breast carcinoma.
The experience with three different chemotherapeutic regimes used as first, second and third line treatment in metastatic breast…